The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation

Antiviral Research

Volumn 36, Issue 1, 1997, Pages 63-72

  Walro, Darlene G ^a   Rosenthal, Ken S ^b  

^a UNIVERSITY OF AKRON   (United States)

^b Northeastern Ohio Medical University   (United States)

Author keywords

Antiviral drug; D609; HSV 1; Protein kinase; Protein phosphorylation; US3 PK

Indexed keywords

ANTIVIRUS AGENT; PROTEIN KINASE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BRIDGED COMPOUNDS; CERCOPITHECUS AETHIOPS; DNA REPLICATION; ENZYME ACTIVATION; HERPESVIRUS 1, HUMAN; PHOSPHORYLATION; PROTEIN KINASES; THIONES; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030869249     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00040-5     Document Type: Article

References (26)

1. Amtmann E., Müller K., Knapp A., Sauer G. Reversion of bovine papillomavirus induced transformation and immortalization by a xanthate compound. Exp. Cell Res. 161:1985;541-550.
2. Amtmann E., Sauer G. Selective killing of tumor cells by xanthates. Cancer Lett. 35:1987;237-244.
3. Blue W.T., Stobbs D.G. Isolation of a protein kinase induced by herpes simplex virus type 1. J. Virol. 38:1981;383-388.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Docherty J.J., Dobson A.T., Trimble J.J., Jennings B.A. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E-5-(2-bromovinyl)-2′-deoxyuridine. Intervirology. 32:1991;308-315.
6. Fenwick M.L., Walker M.J. Suppression of the synthesis of cellular macromolecules by herpes simplex virus. J. Gen. Virol. 46:1978;37-51.
7. Fink D.J., Sternberg L.R., Weber P.C., Mata M., Goins W.F., Glorioso J.C. In vivo expression of β-gal in hippocampal neurons by HSV mediated gene transfer. Hum. Gene Ther. 3:1992;11-19.
8. Frame M.C., Purves F.C., McGeoch D.J., Marsden H.S., Leader D.P. Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J. Gen. Virol. 68:1987;2699-2704.
9. Fürstenberger G., Amtmann E., Marks F., Sauer G. Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis. Int. J. Cancer. 43:1989;508-512.
10. Glorioso J.C., Goins W.F., Meaney C.A., Fink D.J., DeLuca N.A. Gene transfer to brain using HSV vectors. Ann. Neurol. 35:1994;528-534.
11. Katan M., Stevely W., Leader D.P. Partial purification and characterization of a new phosphoprotein kinase from cells infected with pseudorabies virus. Eur. J. Biochem. 152:1985;57-65.
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
13. Leader D.P. Viral protein kinases and protein phosphatases. Pharmac. Ther. 59:1993;343-389.
14. Longnecker E., Roizman B. Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome. Science. 236:1987;573-576.
15. Maniatis, T., Fritsch, E.F., Sambrook, J., 1982. Molecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory, New York, p. 545.
16. Müller-Decker K. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reaction. Biochem. Biophys. Res. Commun. 162:1989;198-205.
17. Müller-Decker K., Amtmann E., Sauer G. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound. J. Gen. Virol. 68:1987;3045-3056.
18. Müller-Decker K., Doppler C., Amtmann E., Sauer G. Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound. Exper. Cell Res. 177:1988;295-302.
19. Purves F.C., Katan M., Leader D.P. Complete purification of the pseudorabies virus protein kinase. Eur. J. Biochem. 167:1987;507-512.
20. Purves F.C., Longnecker R.M., Leader D.P., Roizman B. Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J. Virol. 61:1987;2896-2901.
21. L34 gene. J. Virol. 65:1991;5757-5764.
22. Rosenthal K.S., Hodnichak C.M., Summers J.L. Flow cytometric evaluation of anti-herpes drugs. Cytometry. 8:1987;392-395.
23. Sauer G., Amtmann E., Melber K., Knapp A., Müller K., Hummel K., Scherm A. DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc. Natl. Acad. Sci. USA. 81:1984;3263-3267.
24. Smith R.F., Smith T.F. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J. Virol. 63:1989;450-455.
25. Villanueva N., Navarro J., Cubero E. Antiviral effects of xanthate D609 on the human respiratory syncytial virus growth cycle. Virology. 181:1991;101-108.
26. Wilcox K.W., Kohn A., Skylanskaya E., Roizman B. Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA. J. Virol. 33:1980;167-182.